These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16570107)

  • 1. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake.
    Matias I; Bisogno T; Di Marzo V
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S7-S12. PubMed ID: 16570107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.
    Matias I; Di Marzo V
    J Endocrinol Invest; 2006; 29(3 Suppl):15-26. PubMed ID: 16751706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
    Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O
    Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid system and its role in energy regulation.
    Matias I; Di Marzo V
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):557-569. PubMed ID: 30290459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.
    Kirkham TC; Williams CM; Fezza F; Di Marzo V
    Br J Pharmacol; 2002 Jun; 136(4):550-7. PubMed ID: 12055133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.
    Izzo AA; Piscitelli F; Capasso R; Aviello G; Romano B; Borrelli F; Petrosino S; Di Marzo V
    Br J Pharmacol; 2009 Sep; 158(2):451-61. PubMed ID: 19371345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
    Di Marzo V
    Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of endocannabinoid system in human gliomas.
    Wu X; Han L; Zhang X; Li L; Jiang C; Qiu Y; Huang R; Xie B; Lin Z; Ren J; Fu J
    J Neurochem; 2012 Mar; 120(5):842-9. PubMed ID: 22176552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity.
    Argueta DA; DiPatrizio NV
    Physiol Behav; 2017 Mar; 171():32-39. PubMed ID: 28065722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
    Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
    Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid metabolic pathways and enzymes.
    Ligresti A; Cascio MG; Di Marzo V
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid in the nucleus accumbens enhances the intake of palatable solution.
    Shinohara Y; Inui T; Yamamoto T; Shimura T
    Neuroreport; 2009 Oct; 20(15):1382-5. PubMed ID: 19734811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
    Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
    Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.